01-08-2022 |
AH |
4:05 PM ET (Aug 1) |
EBS |
Emergent Biosolutions, Inc. |
1,570 |
-0.86 |
0.63 |
0.33 |
Emergent Biosolutions Non-GAAP EPS of -$0.86 misses by $1.26, revenue of $242.7M misses by $25.66M [8/1/2022 4:17 PM] |
30.21 |
-4.02 (-11.74%) |
33.94 |
-0.29 (-0.85%) |
26.85 - 66.78 |
1,411,973 |
560,000 |
1,994 |
|
|
28-04-2022 |
AH |
4:05 PM ET (Apr 28) |
EBS |
Emergent Biosolutions, Inc. |
1,870 |
0.18 |
0.23 |
1.53 |
Emergent Biosolutions Non-GAAP EPS of $0.18 beats by $0.11, revenue of $307.5M beats by $24.96M [4/28/2022 4:11 PM] |
32.26 |
-4.36 (-11.90%) |
33.75 |
-2.86 (-7.81%) |
29.88 - 68.03 |
1,146,795 |
530,000 |
5,847 |
|
|
24-02-2022 |
AH |
4:05 PM ET (Feb 24) |
EBS |
Emergent Biosolutions, Inc. |
2,270 |
4.50 |
3.88 |
3.67 |
Emergent Biosolutions Non-GAAP EPS of $4.50 beats by $0.08, revenue of $723.2M beats by $46.28M [2/24/2022 4:14 PM] |
40.89 |
-1.45 (-3.42%) |
42.34 |
0.0 (0.00%) |
29.88 - 102.88 |
274,463 |
530,000 |
9,823 |
|
|
04-11-2021 |
AH |
4:05 PM ET (Nov 4) |
EBS |
Emergent Biosolutions, Inc. |
2,680 |
-0.36 |
2.03 |
2.19 |
Emergent Biosolutions EPS misses by $2.64, misses on revenue [11/4/2021 4:20 PM] |
33.76 |
-18.85 (-35.83%) |
40.05 |
-12.56 (-23.87%) |
29.88 - 127.20 |
6,869,394 |
390,000 |
26,624 |
|
|
29-07-2021 |
AH |
4:05 PM ET (Jul 29) |
EBS |
Emergent Biosolutions, Inc. |
3,360 |
0.33 |
1.81 |
1.98 |
Emergent Biosolutions EPS misses by $1.23, misses on revenue [7/29/2021 4:17 PM] |
65.97 |
0.75 (1.15%) |
62.00 |
-3.22 (-4.94%) |
55.07 - 137.61 |
715,321 |
490,000 |
3,297 |
|
|
29-04-2021 |
AH |
4:05 PM ET (Apr 29) |
EBS |
Emergent Biosolutions, Inc. |
3,430 |
1.53 |
0.97 |
0.01 |
Emergent Biosolutions EPS beats by $0.36, misses on revenue [4/29/2021 4:35 PM] |
60.84 |
-2.31 (-3.66%) |
61.50 |
-1.65 (-2.61%) |
60.70 - 137.61 |
835,432 |
1,140,000 |
2,851 |
|
-
Emergent awaiting FDA OK to release 60M J&J vaccine doses - Bloomberg [4/29/2021 3:06 PM]
-
Emergent Biosolutions EPS beats by $0.36, misses on revenue [4/29/2021 4:35 PM]
-
CDC allocating J&J vaccine again, but still at low numbers [4/30/2021 12:46 PM]
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Arcimoto, Emergent BioSolutions, and Verus International and Encourages Investors to Contact the Firm [Apr-28-21 09:00PM]
-
SHAREHOLDER ALERT: MPLN KDMN EBS: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines [Apr-28-21 05:20PM]
-
Safirstein Metcalf LLP Announces That A Class Action Has Been Filed Against Emergent BioSolutions Inc. - EBS [Apr-28-21 04:00PM]
-
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Emergent Biosolutions Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 18, 2021 - EBS [Apr-28-21 03:08PM]
-
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Emergent BioSolutions (EBS) Investors with $100k+ Losses to Contact Its Attorneys Now, Securities Fraud Case Pending, Firm Investigating CEOs Insider Sales [Apr-28-21 02:25PM]
-
EBS Stock: Berger Montague Investigates Potential Securities Fraud Claims Against Emergent BioSolutions Inc. (EBS); Lead Plaintiff Deadline is June 18, 2021 [Apr-28-21 02:14PM]
-
EBS INVESTOR ALERT: Shareholder Class Action Lawsuit Filed [Apr-28-21 01:00PM]
-
EBS LAWSUIT: The Law Offices of Vincent Wong Notify Investors of a Class Action Lawsuit Involving Emergent Biosolutions Inc. [Apr-28-21 12:45PM]
-
INVESTOR ACTION REMINDER: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Emergent BioSolutions Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm [Apr-28-21 11:02AM]
-
EBS Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Emergent BioSolutions Inc. Investors of Class Action and Encourages Investors to Contact the Firm [Apr-28-21 11:00AM]
-
Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Emergent BioSolutions Inc. (EBS) [Apr-28-21 11:00AM]
-
Class Action Reminder: Labaton Sucharow LLP Reminds Investors of Securities Fraud Class Action Lawsuit Filed Against Emergent BioSolutions Inc. (NYSE: EBS) [Apr-28-21 10:55AM]
-
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of OTRK, LDOS and EBS [Apr-28-21 06:30AM]
-
SHAREHOLDER ALERT: CLAIMSFILER REMINDS EBS, GOEV, RMO INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits [Apr-28-21 10:50PM]
-
EBS EQUITY ALERT: Kessler Topaz Meltzer & Check, LLP Announces that a Securities Fraud Class Action Lawsuit was filed on Behalf of Investors of Emergent BioSolutions Inc. [Apr-28-21 09:55PM]
-
CLASS ACTION UPDATE for SOS, FGEN and EBS: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders [Apr-29-21 06:30AM]
-
EMERGENT SHAREHOLDERS: June 18, 2021 Filing Deadline in Class Action Contact Lieff Cabraser [Apr-29-21 09:01AM]
-
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of BLU, ATNX and EBS [Apr-29-21 10:25AM]
-
EBS Investor Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Emergent BioSolutions Inc. Investors of Class Action and Encourages Investors to Contact the Firm [Apr-29-21 11:00AM]
-
Emergent BioSolutions Inc. Class Action Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Shareholders of Deadline in Securities Fraud Class Action Lawsuit [Apr-29-21 11:11AM]
-
INVESTOR ACTION NOTICE: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Emergent BioSolutions Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm [Apr-29-21 11:35AM]
-
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of PLUG, RIDE and EBS [Apr-29-21 12:30PM]
-
INVESTOR ACTION ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Emergent BioSolutions Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm [Apr-29-21 01:15PM]
-
Emergent BioSolutions Reports Financial Results for First Quarter 2021 [Apr-29-21 04:05PM]
-
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Emergent Biosolutions Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 18, 2021 - EBS [Apr-29-21 04:13PM]
-
UPDATE 1-Emergent BioSolutions posts first-quarter profit on vaccine funding [Apr-29-21 04:55PM]
-
Emergent BioSolutions posts first-quarter profit on vaccine funding [Apr-29-21 04:19PM]
-
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Emergent BioSolutions (EBS) Investors with $100k+ Losses to Contact its Attorneys Now, Securities Fraud Class Action Filed, Application Deadline Established [Apr-29-21 05:03PM]
-
Emergent Biosolutions (EBS) Q1 Earnings Top Estimates [Apr-29-21 05:45PM]
-
UPDATE 2-Emergent hopes to answer U.S. FDA on Baltimore plant within days [Apr-29-21 04:55PM]
-
Emergent hopes to answer U.S. FDA on Baltimore plant within days [Apr-29-21 04:19PM]
-
EMERGENT BIOSOLUTIONS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Emergent BioSolutions Inc. - EBS [Apr-29-21 07:14PM]
-
SHAREHOLDER ACTION NOTICE: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Emergent BioSolutions Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm [Apr-30-21 12:50AM]
-
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Emergent BioSolutions Inc. Investors with Losses Exceeding $100K to Secure Counsel Before Important Deadline - EBS [Apr-29-21 11:02PM]
-
Emergent BioSolutions Inc (EBS) Q1 2021 Earnings Call Transcript [Apr-30-21 05:31AM]
-
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of PLUG, EBON and EBS [Apr-30-21 06:30AM]
-
EMERGENT INVESTORS: June 18, 2021 Filing Deadline in Class Action Contact Lieff Cabraser [Apr-30-21 09:00AM]
-
New Strong Sell Stocks for April 30th [Apr-30-21 09:19AM]
-
CLASS ACTION UPDATE for RIDE, FGEN and EBS: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders [Apr-30-21 10:05AM]
-
Class Action Reminder: Labaton Sucharow LLP Reminds Investors of Securities Fraud Class Action Lawsuit Filed Against Emergent BioSolutions Inc. (NYSE:EBS) [Apr-30-21 10:45AM]
-
Emergent (EBS) Beats on Q1 Earnings, Cuts Contract Revenue View [Apr-30-21 10:06AM]
-
DEADLINE ALERT for FUV, EBS, and ACAD: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders [Apr-30-21 11:00AM]
-
EBS Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Emergent BioSolutions Inc. Investors of Class Action and Encourages Shareholders to Contact the Firm [Apr-30-21 11:00AM]
-
SHAREHOLDER ACTION ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Emergent BioSolutions Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm [Apr-30-21 11:40AM]
-
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Emergent BioSolutions Inc. (EBS) [Apr-30-21 12:30PM]
-
LAWSUITS FILED AGAINST FGEN, CAN and EBS - Jakubowitz Law Pursues Shareholders Claims [Apr-30-21 12:45PM]
-
Deadline Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Securities Fraud Class Action Lawsuit Filed Against Emergent BioSolutions Inc. (EBS) [Apr-30-21 02:03PM]
-
Emergent BioSolutions Hopeful To Restart Vaccine Production, Plans To Submit Response To FDA Within Days [Apr-30-21 11:14AM]
-
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of VLDR, REGI and EBS [Apr-30-21 02:30PM]
-
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Emergent BioSolutions Inc. Investors with Losses to Secure Counsel Before Important Deadline EBS [Apr-30-21 07:36PM]
-
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Emergent BioSolutions (EBS) Investors with $100k+ Losses to Contact its Attorneys Now, Securities Class Action Filed, Application Deadline Approaching [Apr-30-21 07:00PM]
-
Emergent BioSolutions Inc. -- Moody's affirms Emergent's Ba2 CFR; revises outlook to negative [Apr-30-21 05:55PM]
-
Emergent BioSolutions Has Supply Of 60M Johnson & Johnson COVID-19 Vaccine Doses Awaiting Approval: Bloomberg [Apr-30-21 02:35PM]
-
Canada to not distribute JNJ COVID-19 vaccines until quality checks complete [Apr-30-21 08:01PM]
-
UPDATE 1-Canada receives J&J's COVID-19 vaccine from plant where FDA halted production [Apr-30-21 08:20PM]
|
18-02-2021 |
AH |
4:05 PM ET (Feb 18) |
EBS |
Emergent Biosolutions, Inc. |
6,630 |
3.67 |
2.72 |
1.57 |
Emergent Biosolutions EPS beats by $0.26, beats on revenue [2/18/2021 4:28 PM] |
102.94 |
-14.12 (-12.07%) |
111.27 |
-5.79 (-4.95%) |
46.37 - 137.61 |
1,980,724 |
440,707 |
4,959 |
|
|
05-11-2020 |
AH |
4:25 PM ET (Nov 5) |
EBS |
Emergent Biosolutions, Inc. |
4,910 |
2.19 |
2.05 |
1.21 |
Emergent Biosolutions EPS beats by $0.04, misses on revenue, revised FY20 guidance [11/5/2020 5:40 PM] |
92.04 |
-4.96 (-5.11%) |
93.35 |
-3.65 (-3.76%) |
46.37 - 137.61 |
685,634 |
484,972 |
4,178 |
|
|
30-07-2020 |
AH |
4:10 PM ET (Jul 30) |
EBS |
Emergent Biosolutions, Inc. |
4,850 |
1.98 |
0.53 |
0.12 |
Emergent Biosolutions beats on revenue [7/30/2020 4:39 PM] |
110.21 |
13.19 (13.60%) |
104.03 |
7.01 (7.23%) |
39.11 - 114.13 |
1,053,110 |
1,945,492 |
4,523 |
|
|